Two Sigma Advisers’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.27M | Sell |
|
|||||
|
2025
Q2 | $4.94M | Buy |
|
|||||
|
2025
Q1 | $5.08M | Buy |
|
|||||
|
2024
Q4 | $46.6K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $53K | Buy |
|
|||||
|
2024
Q1 | $22.3K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $34K | Sell |
|
|||||
|
2022
Q2 | $101K | Buy |
|
|||||
|
2022
Q1 | $33K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $293K | Buy |
|
|||||
|
2021
Q1 | $93K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $118K | Sell |
|
|||||
|
2020
Q2 | $155K | Buy |
|
|||||
|
2020
Q1 | $63K | Buy |
|